CAMBRIDGE, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate…
Proposed Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company developing novel treatments targeting STAT3 to treat fibrosis-driven diseases Tvardi has…
ALK’s peanut tablet shown to be safe and tolerable across multiple doses.Development now advances to phase II for dose finding…
The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer…
When compared to placebo, prophylactic administration of INNA-051 was associated with significantly increased expression of multiple host defense genes and…
- Pursuing Divestiture of CertainT® Platform, Implements Changes to Corporate Leadership -- Build-out of GMP Manufacturing Facility to be Completed…
The interview with Dr. John Barr and Jim Patton tackles medication safety and how PillSafe Technologies secures prescriptions, prevents abuse,…
Exeltis will be granted an exclusive license to market and distribute Theranexus' novel formulation TX01 for the treatment of two…
LYON, FRANCE / ACCESSWIRE / December 17, 2024 / Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological…
Strategic investment from Google and acceptance into Mayo Clinic Platform Accelerate program show an increasing understanding of Ubie's value to patients…